← Back to directory

Estrid Høgdall

Researcher Next ID · RN-038612

Researcher · Biochemistry, Genetics and Molecular Biology

University of Copenhagen

Copenhagen, Denmark

Accepting doctoral researchersFunding unknown
Works count
713
Citation count
24,380
H-index
78
i10-index
334

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Ovarian cancer diagnosis and treatment
BRCA gene mutations in cancer
Cancer-related molecular mechanisms research
Cancer Genomics and Diagnostics
Endometrial and Cervical Cancer Treatments

Publications

  • RNA profiles reveal signatures of future health and disease in pregnancy

    Nature · 2022 · 10.1038/s41586-021-04249-w

  • European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer

    Annals of Oncology · 2021 · 10.1016/j.annonc.2021.11.013

  • Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D

    JNCI Journal of the National Cancer Institute · 2020 · 10.1093/jnci/djaa030

  • Dose-Response Association of CD8 + Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer

    JAMA Oncology · 2017 · https://doi.org/10.1001/jamaoncol.2017.3290

  • Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma

    Cell · 2017 · https://doi.org/10.1016/j.cell.2017.09.027

  • Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

    Cancer Discovery · 2016 · https://doi.org/10.1158/2159-8290.cd-15-1227

  • Continuing rise in oropharyngeal cancer in a high HPV prevalence area: A Danish population-based study from 2011 to 2014

    European Journal of Cancer · 2016 · https://doi.org/10.1016/j.ejca.2016.10.015

  • Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population

    Journal of Clinical Oncology · 2015 · https://doi.org/10.1200/jco.2015.61.2408

  • Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

    PLoS ONE · 2015 · https://doi.org/10.1371/journal.pone.0128106

  • ABCA Transporter Gene Expression and Poor Outcome in Epithelial Ovarian Cancer

    JNCI Journal of the National Cancer Institute · 2014 · https://doi.org/10.1093/jnci/dju149

  • Aspirin, Nonaspirin Nonsteroidal Anti-inflammatory Drug, and Acetaminophen Use and Risk of Invasive Epithelial Ovarian Cancer: A Pooled Analysis in the Ovarian Cancer Association Consortium

    JNCI Journal of the National Cancer Institute · 2014 · https://doi.org/10.1093/jnci/djt431

  • Human Papillomavirus Genotyping and p16 Expression As Prognostic Factors for Patients With American Joint Committee on Cancer Stages I to III Carcinoma of the Anal Canal

    Journal of Clinical Oncology · 2014 · 10.1200/jco.2013.52.3464

  • Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium

    Endocrine Related Cancer · 2013 · 10.1530/erc-12-0395

  • Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study

    The Lancet Oncology · 2013 · https://doi.org/10.1016/s1470-2045(13)70253-5

  • GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

    Nature Genetics · 2013 · https://doi.org/10.1038/ng.2564

  • Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium

    Endocrine Related Cancer · 2013 · 10.1530/erc-12-0395

  • Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies

    International Journal of Epidemiology · 2013 · 10.1093/ije/dyt042

  • MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer — A multicenter prospective comparative study

    Gynecologic Oncology · 2012 · https://doi.org/10.1016/j.ygyno.2012.11.025

  • Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass

    Gynecologic Oncology · 2012 · 10.1016/j.ygyno.2012.07.106

  • Evaluation of HE4, CA125, risk of ovarian malignancy algorithm (ROMA) and risk of malignancy index (RMI) as diagnostic tools of epithelial ovarian cancer in patients with a pelvic mass

    Gynecologic Oncology · 2012 · 10.1016/j.ygyno.2012.07.106

  • Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies

    The Lancet Oncology · 2012 · https://doi.org/10.1016/s1470-2045(11)70404-1

  • A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24

    Nature Genetics · 2010 · https://doi.org/10.1038/ng.668

  • Common variants at 19p13 are associated with susceptibility to ovarian cancer

    Nature Genetics · 2010 · https://doi.org/10.1038/ng.666

  • A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2

    Nature Genetics · 2009 · https://doi.org/10.1038/ng.424

  • Multiple Loci With Different Cancer Specificities Within the 8q24 Gene Desert

    JNCI Journal of the National Cancer Institute · 2008 · 10.1093/jnci/djn190

  • The diagnostic value of PET/CT for primary ovarian cancer—A prospective study

    Gynecologic Oncology · 2007 · 10.1016/j.ygyno.2006.11.022

  • The Absolute Risk of Cervical Abnormalities in High-risk Human Papillomavirus–Positive, Cytologically Normal Women Over a 10-Year Period

    Cancer Research · 2006 · 10.1158/0008-5472.can-06-1057

  • Adverse Reactions to Injectable Soft Tissue Permanent Fillers

    Aesthetic Plastic Surgery · 2005 · 10.1007/s00266-004-0113-6

Current projects

    No projects listed.